Why Kenya is betting on regulatory reforms to unlock pharmaceutical growth
Speaking at the 46th Annual Pharmaceutical Society of Kenya Conference in Mombasa, Duale said the government had made the achievement of WHO Maturity Level 3 (ML3) recognition a key priority and had already carried out major reforms to address gaps that have held the country back.
Maureen Kinyanjui